FTC Judge Says Lives At Stake In Cancer Test Deal Challenge
By Matthew Perlman · June 9, 2022, 6:35 PM EDT
Federal Trade Commission staffers pressed their bid to block Illumina's $8 billion reacquisition of cancer testing outfit Grail during closing arguments, as the agency's administrative law judge questioned whether getting the...
To view the full article, register now.